KEVIN JACKSON: Open Payments
NPI 1871986083 · CELINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $183 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| ABBVIE INC. | 3 | $47 |
| Novo Nordisk Inc | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $18 |
| Abbott Laboratories | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: REXULTI, QULIPTA, Wegovy, Auvelity, BREZTRI, MOUNJARO, FREESTYLE LIBRE 3, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
